PRECIRIX

Key figures

Burgemeester Etienne Demunterlaan 3
B-1090 Brussels

https://www.precirix.com/
info@precirix.com
+32 2 479 93 60
PRECIRIX

PRECIRIX is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments.

Activities and description

Targeted market

Ongoing projects/partnerships/collaborations